Cardiol Therapeutics Inc.

NASDAQ: CRDL · Real-Time Price · USD
1.31
-0.03 (-2.24%)
At close: Aug 15, 2025, 12:22 PM

Cardiol Therapeutics Income Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 78.76K n/a
Cost of Revenue
n/a n/a n/a 61.91K 61.62K 66.76K 64.89K 58.5K 58.2K 58.03K 54.48K 53.78K 53.62K 55.59K 55.59K n/a 54.62K
Gross Profit
n/a n/a n/a -61.91K -61.62K -66.76K -64.89K -58.5K -58.2K -58.03K -54.48K -53.78K -53.62K -55.59K -55.59K 78.76K -54.62K
Operating Income
-8.43M n/a -14.14M -7.74M -8.41M -8.03M -7.66M -4.63M -7.94M -10.09M -17.91M -11.78M -10.55M -19.89M -10.29M -6.26M -9.03M
Interest Income
248.27K 306.77K 201.86K 307.41K 377.29K 448.30 515.54K 528.7K 545.93K 584.65K 389.34K 191.34K 72.31K 27.77K 35.93K 25.48K 16.82K
Pretax Income
-8.29M -8.18M -12.73M -6.59M -9.18M -7.64M -5.93M -7.47M -7.09M -7.52M -7.97M -6.49M -8.95M -6.26M -9.91M -6.56M -8.91M
Net Income
-8.29M -8.18M -12.73M -6.59M -9.18M -7.64M -5.93M -7.47M -7.09M -7.52M -7.97M -6.49M -8.95M -6.26M -9.91M -6.56M -8.91M
Selling & General & Admin
4.65M 5.76M 10.39M 5.03M 5.02M 3.92M 5.08M 2.84M 3.66M 3.48M 8.13M 4.83M 5.94M 9.57M 7.57M 4.55M 6.32M
Research & Development
3.76M 4.23M 3.75M 2.71M 3.32M 4.04M 2.58M 3.48M 4.13M 5.62M 5.09M 4.41M 3.85M 3.53M 2.59M 1.9M 2.61M
Other Expenses
24.99K n/a n/a n/a 28.22K n/a n/a n/a n/a n/a n/a n/a n/a 19.15K 93.08K n/a n/a
Operating Expenses
8.43M 9.99M 14.14M 7.74M 8.34M 7.96M 7.66M 6.31M 7.79M 9.1M 13.22M 9.23M 9.79M 13.1M 10.16M 6.5M 8.98M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -61.62K 3.92M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
8.43M 9.99M 14.14M 7.74M 8.41M 8.03M 7.66M 6.31M 7.79M 9.1M 13.22M 9.23M 9.79M 13.1M 10.16M 6.5M 8.98M
Income Tax Expense
n/a n/a n/a n/a -2 -2 n/a 1.16M -696.8K -1.58M -5.08M -2.74M -834.38K -6.82M -160.54K 137.63K -70.36K
Shares Outstanding (Basic)
82.61M 69.84M 69.84M 68.75M 67.26M 65.35M 64.49M 64.11M 64.09M 63.83M 62.34M 61.93M 61.92M 56.89M 43.17M 40.06M 34.6M
Shares Outstanding (Diluted)
82.61M 69.84M 69.84M 68.75M 67.26M 65.35M 64.49M 64.11M 64.09M 64.04M 62.34M 61.93M 61.93M 56.89M 43.17M 40.06M 34.61M
EPS (Basic)
-0.1 -0.12 -0.18 -0.1 -0.14 -0.12 -0.09 -0.12 -0.11 -0.12 -0.13 -0.1 -0.14 -0.11 -0.23 -0.16 -0.26
EPS (Diluted)
-0.1 -0.12 -0.18 -0.1 -0.14 -0.12 -0.09 -0.12 -0.11 -0.12 -0.13 -0.1 -0.14 -0.11 -0.23 -0.16 -0.26
EBITDA
-8.4M -9.94M -13.94M -7.68M -8.34M -7.96M -7.61M -6.26M -7.73M -9.08M -13.17M -9.18M -9.73M -13.08M -10.11M -6.37M -8.93M
EBIT
-8.43M -9.99M -14.14M -7.74M -8.41M -8.03M -7.66M -6.31M -7.79M -9.1M -13.22M -9.23M -9.79M -13.1M -10.16M -6.42M -8.98M
Depreciation & Amortization
24.99K 48.49K 201.09K 61.91K 61.62K 66.76K 64.89K 58.5K 58.2K 58.03K 54.48K 53.78K 53.62K 55.59K 55.59K 54.62K 54.62K